Burkett Financial Services’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$28.9K Sell
335
-250
-43% -$22K 0.01% 208
2026
Q2
$45.8K Hold
585
– – 0.01% 106
2026
Q1
$50.7K Buy
585
+150
+34% +$14.4K 0.02% 96
2025
Q4
$41.8K Hold
435
– – 0.01% 109
2025
Q3
$41.4K Buy
435
+150
+53% +$13.8K 0.01% 102
2025
Q2
$24.8K Hold
285
– – 0.01% 119
2025
Q1
$25.6K Buy
285
+185
+185% +$16.6K 0.01% 123
2024
Q4
$7.99K Hold
100
– – ﹤0.01% 148
2024
Q3
$9K Hold
100
– – ﹤0.01% 140
2024
Q2
$7.87K Hold
100
– – ﹤0.01% 144
2024
Q1
$8.71K Hold
100
– – ﹤0.01% 148
2023
Q4
$8.24K Buy
+100
New +$7.62K ﹤0.01% 142

Other funds holding MDT

Burkett Financial Services's MDT Position: Q3 2026 in Review

Burkett Financial Services reduced its Medtronic (MDT) stake by 43% in Q3 2026, selling an estimated $22K and leaving 335 shares worth $28.9K. The position accounts for 0.01% of the portfolio, ranked #208.

Burkett Financial Services first reported a position in MDT in Q4 2023 and has held it in 12 quarters since. The position peaked at $50.7K in Q1 2026. 119 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

  • Burkett Financial Services held 335 shares of Medtronic worth $28.9K as of Q3 2026.
  • Burkett Financial Services sold 250 Medtronic shares in Q3 2026, an estimated $22K.
  • Medtronic made up 0.01% of Burkett Financial Services's portfolio in Q3 2026, its #208 holding.
  • Burkett Financial Services first reported a position in Medtronic in Q4 2023 and has held it in 12 quarters since.
  • Burkett Financial Services's Medtronic position peaked at $50.7K in Q1 2026.
  • 119 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on Burkett Financial Services's 13F filing for Q3 2026, filed 1 Oct 2026.